Systematic assessment of the impact of oral appliance therapy on the temporomandibular joint during treatment of obstructive sleep apnea: long-term evaluation.

Institute of Research and Development IP&D, University of Vale do Paraíba, São Paulo, Brazil.
Sleep And Breathing (Impact Factor: 2.26). 05/2009; 13(4):375-81. DOI: 10.1007/s11325-009-0257-3
Source: PubMed

ABSTRACT The aim of the present study was to evaluate the symptoms of temporomandibular dysfunction (TMD) in patients with obstructive sleep apnea treated with long-term use of an oral appliance (OA) using a questionnaire based on the Helkimo Anamnestic Dysfunction Index. A further aim of the study was to evaluate the presence of daytime sleepiness using the Epworth Sleep Scale (ESS) and otologic symptoms.
Polysomnograms of 34 patients were performed at baseline and after 6 months of OA use. As follow-up, the patients were contacted by telephone interview to answer the same questionnaires after 36.0 +/- 17.0 months.
The intensity of TMD symptoms decreased significantly throughout treatment (p < 0.01). ESS values improved from 12.2 +/- 5.0 to 6.9 +/- 2.6 (p < or = 0.05). Tinnitus was present in nine patients at baseline and decreased in intensity in seven patients by the final assessment while remaining at the same level in two patients.
We conclude that long-term usage of an OA does not cause impairment to the temporomandibular joint. The Helkimo and otologic indexes are simple and useful in long-term patient follow-up. There was a long-term improvement in the ESS values over the years analyzed. A follow-up program could increase compliance by motivating patients to use the device regularly.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this review is to provide guidelines for the use of oral appliances (OAs) for the treatment of snoring and obstructive sleep apnoea (OSA) in Australia. A review of the scientific literature up to June 2012 regarding the clinical use of OAs in the treatment of snoring and OSA was undertaken by a dental and medical sleep specialists team consisting of respiratory sleep physicians, an otolaryngologist, orthodontist, oral and maxillofacial surgeon and an oral medicine specialist. The recommendations are based on the most recent evidence from studies obtained from peer reviewed literature. Oral appliances can be an effective therapeutic option for the treatment of snoring and OSA across a broad range of disease severity. However, the response to therapy is variable. While a significant proportion of subjects have a near complete control of the apnoea and snoring when using an OA, a significant proportion do not respond, and others show a partial response. Measurements of baseline and treatment success should ideally be undertaken. A coordinated team approach between medical practitioner and dentist should be fostered to enhance treatment outcomes. Ongoing patient follow-up to monitor treatment efficacy, OA comfort and side effects are cardinal to long-term treatment success and OA compliance.
    Australian Dental Journal 12/2013; 58(4):408-19. DOI:10.1111/adj.12111 · 1.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Obstructive sleep apnea (OSA) is increasingly being recognized by the public due to its life-threatening and low curability rate nature. Oral appliances (OAs) were introduced as a treatment option for both non-apneic snoring and OSA to maintain the patency of the upper airway during sleep by repositioning the mandible, tongue, and soft palate. RESULTS: Over the past decade, OAs are enthusiastically studied and concluded as a simple, silent, bed partner-friendly, less invasive, tolerable, and efficacious choice for mild-to-moderate OSA. In the meantime, some challenges remain uncertain such as titration management, 3D image diagnostic tools reliability, and long-term adherence for adult patients. Improvement of temporomandibular joint (TMJ) monitoring and management is recommended, although there is no scientific evidence suggesting consistent undesirable long-term effects of OA on the TMJ. Now that pediatric OSA is being diagnosed more frequently, OA therapy is becoming a promising option for children as well. CONCLUSION: Consistent follow-up and management are needed to increase clinical success rates in OA therapy for OSA. Further educational preparation and support is required for dental and medical professionals to recognize OSA and ensure the best possible patient care.
    Sleep And Breathing 05/2012; DOI:10.1007/s11325-012-0712-4 · 2.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Oral appliances (OA) have emerged as an alternative to continuous positive airway pressure (CPAP) for Obstructive Sleep Apnoea (OSA) treatment. The most commonly used OA reduces upper airway collapse by advancing the mandible (OAm). There is a strong evidence base demonstrating OAm improve OSA in the majority of patients, including some with more severe disease. However OAm are not efficacious for all, with approximately one third of patients experiencing no therapeutic benefit. OAm are generally well tolerated, although short-term adverse effects during acclimatization are common. Long-term dental changes do occur, but these are for the most part subclinical and do not preclude continued use. Patients often prefer OAm to gold-standard Continuous Positive Airway Pressure (CPAP) treatment. Head-to-head trials confirm CPAP is superior in reducing OSA parameters on polysomnography, however this greater efficacy does not necessarily translate into better health outcomes in clinical practice. Comparable effectiveness of OAm and CPAP has been attributed to higher reported nightly use of OAm, suggesting that inferiority in reducing apneic events may be counteracted by greater treatment adherence. Recently, significant advances in commercially available OAm technologies have been made. Remotely controlled mandibular positioners have the potential to identify treatment responders and the level of therapeutic advancement required in single night titration polysomnography. Objective monitoring of OAm adherence using small embedded temperature sensing data loggers is now available and will enhance clinical practice and research. These technologies will further enhance efficacy and effectiveness of OAm treatment for OSA.
    Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 02/2014; 10(2):215-227. DOI:10.5664/jcsm.3460 · 2.83 Impact Factor

Full-text (2 Sources)

Available from
May 15, 2014